Rubix LS taking healthcare to a new level │ Deconstruction Lymphoma one matrix at a time

By Kari Feldt

Rubix LS is an emerging startup firm (2016) from Boston which has already, just after one year, managed to show new groundbreaking possibilities within healthcare. They are working on solving the world’s complex problems by cross-pollinating past, present and future technologies. In one of their latest press release they how they have managed to remove lymphoma cells, without surgical intervention.

“Bringing Tomorrow. Today” (Reginald Swift, CEO)

Lymphoma is a disease where cancer cells are forming in the lymph system. The malignant cancer cells cause the lymphoma to form in the CNS areas, i.e. it may start in the brain or the spinal cord. The traditional and historical treatment has been chemotherapy, which comes with an awful lot of horrible side effects for the patient. By using carefully engineered proteins and ligands, carried in a Nano-matrix, Rubix LS have managed to deconstruct diseases cells in test animals. This way they can target only the diseased cells, and not the healthy tissue. This Nano-matrix structure function like a transport device for the cancer cells killing chemistries.

This new leading edge of medicine-technology opens up new possibilities to treat diseases we have not been able to treat before, at the same time as we put the patients through minimal negative side effects.

  • So why does this matter for you?

Rubix LS press release about how they have managed to use nanotechnology to treat life threatening diseases like cancer is a huge reminder of how important it is to keep up to date on new research. The absent of this knowledge might in the future be the difference between life and death because you don’t know what new treatments there are out there for your patients.

By signing up to the CE App you will get curated content in your profile so you can keep up to date on your continuing education at all times. We will also keep all your certificates in one place so you know how far ahead you are in the process of getting enough credits for your license demands.


Although journals and non-accredited content providers have incredibly valuable resources that are up-to-date, medical professionals are in many cases unable to receive credit for the content they read. Thus, content providers should consider making their material accredited.

Advanced Continuing Education Association (ACEA)



Press Release